DAO
D-amino-acid oxidase
Also known as: DAAO, DAMOX, OXDA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P14920
- Gene
- DAO
- Ensembl
- ENSG00000110887
- Chromosome
- 12
- Canonical length
- 347 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes the peroxisomal enzyme D-amino acid oxidase. The enzyme is a flavoprotein which uses flavin adenine dinucleotide (FAD) as its prosthetic group. Its substrates include a wide variety of D-amino acids, but it is inactive on the naturally occurring L-amino acids. Its biological function is not known; it may act as a detoxifying agent which removes D-amino acids that accumulate during aging. In mice, it degrades D-serine, a co-agonist of the NMDA receptor. This gene may play a role in the pathophysiology of schizophrenia. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
347 residues, UniProt reviewed canonical sequence.
>P14920|DAO
1 MRVVVIGAGV IGLSTALCIH ERYHSVLQPL DIKVYADRFT PLTTTDVAAG LWQPYLSDPN
61 NPQEADWSQQ TFDYLLSHVH SPNAENLGLF LISGYNLFHE AIPDPSWKDT VLGFRKLTPR
121 ELDMFPDYGY GWFHTSLILE GKNYLQWLTE RLTERGVKFF QRKVESFEEV AREGADVIVN
181 CTGVWAGALQ RDPLLQPGRG QIMKVDAPWM KHFILTHDPE RGIYNSPYII PGTQTVTLGG
241 IFQLGNWSEL NNIQDHNTIW EGCCRLEPTL KNARIIGERT GFRPVRPQIR LEREQLRTGP
301 SNTEVIHNYG HGGYGLTIHW GCALEAAKLF GRILEEKKLS RMPPSHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DAO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 140 nTPM
Expression across tissuesHPA
Tissue
- liver: 140 nTPM
- kidney: 84 nTPM
- cerebellum: 48 nTPM
- spinal cord: 34 nTPM
- midbrain: 17 nTPM
- retina: 11 nTPM
Single-cell type
- bergmann glia: 133 nCPM
- hepatocytes: 53 nCPM
- proximal tubule cells: 20 nCPM
- astrocytes: 14 nCPM
- rod photoreceptor cells: 12 nCPM
- syncytiotrophoblasts: 7.7 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 151 nTPM
- white matter: 123 nTPM
- spinal cord: 95 nTPM
- medulla oblongata: 90 nTPM
- pons: 60 nTPM
- midbrain: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DAO.
Disease | AllUniProt
Conditions DAO is implicated in, by any mechanism.
- Schizophrenia (SCZD) MIM:181500
- Amyotrophic lateral sclerosis (ALS) MIM:105400
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.11
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- D-amino acid catabolic process
- D-serine metabolic process
- digestion
- dopamine biosynthetic process
- L-proline catabolic process
- neutrophil-mediated killing of gram-negative bacterium
- D-alanine catabolic process
- D-serine catabolic process
- L-leucine metabolic process
Molecular functions
- FAD binding
- identical protein binding
- D-amino-acid dehydrogenase activity
- D-amino-acid oxidase activity
- glycine oxidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DAO in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DAO as an antibody target. Whether an autoantibody or antibody against DAO could matter depends on whether native DAO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DAO is annotated as secreted, so native DAO circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label DAO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...